Lead party: International Finance Corporation (IFC) (investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Aspen Pharmacare Holdings Limited (public company) · Sector: Healthcare, Biotechnology, Medical Supplies, Pharmaceuticals · Countries of operation: Tanzania, Uganda, Mauritius, South Africa, Ghana, Nigeria, Botswana, Namibia, Kenya
Transaction type: Debt Financing · Asset class: Private Credit · Strategy: Direct Lending · Instrument: Syndicated Loan · Round: Growth Capital · Deal amount: US$714.1m · Fund: European Financing Partners S. A, EFP
Investors/buyers: International Finance Corporation (IFC), Proparco, Deutsche Investitions-und Entwicklungsgesellschaft (DEG), The United States International Development Finance Corporation (DFC), Austrian Development Bank (OeEB), EDFI Management Company
Legal advisers: not identified in the source record.
Source: announced 30 June 2021. Original announcement: ifc.org.


